Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 535  
CASE REPORT
Year : 2018  |  Volume : 17  |  Issue : 3  |  Page : 207-210

Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer


1 Department of Nuclear Medicine, Faculty of Medicine, Kuwait University, Kuwait
2 Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey
3 Department of Nuclear Medicine, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait

Correspondence Address:
Ismet Sarikaya
Department of Nuclear Medicine, Faculty of Medicine, Kuwait University, PO Box 24923, 13110 Safat
Kuwait
Login to access the Email id


DOI: 10.4103/wjnm.WJNM_51_17

PMID: 30034289

Rights and Permissions

Various positron emission tomography (PET) studies are available for prostate cancer which show various successes at demonstrating primary, recurrent, or metastatic tumor and assessing response to treatment. In this case report, we will present and compare pre- and post-therapy fluorodeoxyglucose, sodium fluoride, and gallium-68 prostate-specific membrane antigen PET images of a patient with prostate cancer.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1433    
    Printed37    
    Emailed0    
    PDF Downloaded181    
    Comments [Add]    

Recommend this journal